Get started
Author

Oliver Renner

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
2008 · Amancio Carnero, Carmen Blanco-Aparicio, et al. · Current Cancer Drug Targets · 905
Pericytes and the Pathogenesis of Diabetic Retinopathy
2002 · Hans-Peter Hammes, Jihong Lin, et al. · Diabetes · 680
PDF
Absence of Glial Fibrillary Acidic Protein and Vimentin Prevents Hypertrophy of Astrocytic Processes and Improves Post-Traumatic Regeneration
2004 · Ulrika Wilhelmsson, Lizhen Li, et al. · Journal of Neuroscience · 466
PDF
PTEN, more than the AKT pathway
2007 · Carmen Blanco-Aparicio, Oliver Renner, et al. · Carcinogenesis · 409
Angiopoietin-2 Causes Pericyte Dropout in the Normal Retina
2004 · Hans-Peter Hammes, Jihong Lin, et al. · Diabetes · 348
PDF
Transcription Profiling of Platelet-Derived Growth Factor-B-Deficient Mouse Embryos Identifies RGS5 as a Novel Marker for Pericytes and Vascular Smooth Muscle Cells
2003 · Cecilia Bondjers, Mattias Kalén, et al. · American Journal Of Pathology · 246
PDF
Time- and cell type-specific induction of platelet-derived growth factor receptor-β during cerebral ischemia
2003 · Oliver Renner, Asterios Tsimpas, et al. · Molecular Brain Research · 106
Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells
2010 · F Zanella, O Renner, et al. · Oncogene · 103
The Expression of Constitutively Active Isotypes of Protein Kinase C to Investigate Preconditioning
1998 · Jing Zhao, Oliver Renner, et al. · Journal of Biological Chemistry · 94
PDF
Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases
2009 · Wolfgang Link, Julen Oyarzabal, et al. · Journal of Biological Chemistry · 83
Cooperation between Cdk4 and p27kip1 in Tumor Development: A Preclinical Model to Evaluate Cell Cycle Inhibitors with Therapeutic Activity
2005 · Rocío Sotillo, Oliver Renner, et al. · Cancer Research · 56
Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation
2008 · Oliver Renner, Carmen Blanco-Aparicio, et al. · Cancer Research · 47
Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer
2006 · Carmen Blanco-Aparicio, Lucía Pérez-Gallego, et al. · Carcinogenesis · 46
Cellular proteins bind to the downstream component of the lytic origin of DNA replication of Epstein-Barr virus
1995 · H Gruffat, O Renner, et al. · Journal of Virology · 44
PDF
Upregulation of the Cochaperone Mdg1 in Endothelial Cells Is Induced by Stress and during in Vitro Angiogenesis
2001 · Felicitas Pröls, Matthias P. Mayer, et al. · Experimental Cell Research · 40
Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
2010 · Carmen Blanco-Aparicio, Marta Cañamero, et al. · PLoS ONE · 32
PDF
Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens
2014 · Enara Aguirre, Oliver Renner, et al. · Frontiers in Oncology · 27
PDF
Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate
2007 · Oliver Renner, Jesus Fominaya, et al. · Carcinogenesis · 25
Mouse Models to Decipher the PI3K Signaling Network in Human Cancer
2009 · Oliver Renner, Amancio Carnero · Current Molecular Medicine · 24
Genetic modelling of the PTEN/AKT pathway in cancer research
2008 · Oliver Renner, Carmen Blanco-Aparicio, et al. · Clinical & Translational Oncology · 20
Nucleotide sequence of the genes encoding the subunits H, B, A′ and A″ of te DNA-dependent RNA polymerase and the initiator tRNA fromThermoplasma acidophilum
1992 · Hans-Peter Klenk, Oliver Renner, et al. · Nucleic Acids Research · 16
The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab
2024 · Barbara Vogg, Johann Poetzl, et al. · Clinical Therapeutics · 8
PDF
Exploring cellular senescence as a tumor suppressor mechanism
2003 · Amancio Carnero, Carmen Blanco, et al. · Revista de Oncología · 8
Correction: Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
2013 · Maja Narlik-Grassow, Carmen Blanco-Aparicio, et al. · PLoS ONE · 4
PDF
Abstract A275: Co-targeting PIM and PI3K/mTOR pathways with a single molecule: Novel orally available combined PIM/PI3K and PIM/PI3K/mTOR kinase inhibitors.
2013 · Carmen Blanco Aparicio, Oliver Renner, et al. · Molecular Cancer Therapeutics · 2
Works count: 45
Citation count: 3,840
H-index: 20
I10-index: 21
Year
Topic
Type